Lazertinib

For research use only.

Catalog No.S8724 Synonyms: YH25448,GNS-1480

1 publication

Lazertinib Chemical Structure

Molecular Weight(MW): 554.64

Lazertinib (YH25448,GNS-1480) is a potent, highly mutant-selective and irreversible EGFR-TKI with IC50 values of 1.7 nM, 2 nM, 5 nM, 20.6 nM and 76 nM for Del19/T790M, L858R/T790M, Del19, L85R and Wild type EGFR respectively, showing much higher IC50 values aganist ErbB2 and ErbB4.

Size Price Stock Quantity  
USD 227 In stock
USD 690 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Selleck's Lazertinib has been cited by 1 publication

Purity & Quality Control

Choose Selective EGFR Inhibitors

Biological Activity

Description Lazertinib (YH25448,GNS-1480) is a potent, highly mutant-selective and irreversible EGFR-TKI with IC50 values of 1.7 nM, 2 nM, 5 nM, 20.6 nM and 76 nM for Del19/T790M, L858R/T790M, Del19, L85R and Wild type EGFR respectively, showing much higher IC50 values aganist ErbB2 and ErbB4.
Targets
Del19/T790M [1]
(Cell-free assay)
L858R/T790M EGFR [1]
(Cell-free assay)
Del19 [1]
(Cell-free assay)
L85R [1]
(Cell-free assay)
WT EGFR [1]
(Cell-free assay)
1.7 nM 2 nM 5 nM 20.6 nM 76 nM
In vitro

Lazertinib targets the activating EGFR mutations Del19 and L858R, as well as the T790M mutation, while sparing wild type. In NSCLC cell lines and primary cancer cells from patients harboring EGFR mutations, YH25448 more potently inhibits cancer cell growth and significantly increases tumor cell apoptosis compared to osimertinib[1]. In the cell proliferation assays, GI50 values of lazertinib are 6 nM, 5 nM, and 711 nM for H1975 cells (L858R/T790M), PC9 cells (del19) and H2073 cells (wt), respectively[2].

In vivo

In an in vivo mouse model implanted with H1975 cells, once-daily YH25448 treatment results in indramatic dose-dependent tumor regression in both subcutaneous and intracranial lesions with no abnormal signs such as skin keratosis. The plasma half-life of YH25448 is 5.9-6.8 hr, while the tumor to plasma AUC0-last ratio is 3.0-5.1 in tumor-bearing mice. YH25448 shows excellent penetration of the blood-brain bartier, achieving CSF concentrations exceeding the IC50 value for pEGFR inhibition. YH25448 shows superior efficacy for tumor regression in an EGFR mutant brain metastasis model[1].

Protocol

Cell Research:

[1]

- Collapse
  • Cell lines: Ba/F3 cells
  • Concentrations: 5, 10, 100 nM
  • Incubation Time: 6 h
  • Method:

    Ba/F3 cells overexpressing the indicated EGFR mutant are treated with YH25448 or osimertinib for 6 hours at the indicated concentrations. pEGFR levels are detected by Western blot analysis.


    (Only for Reference)
Animal Research:

[1]

- Collapse
  • Animal Models: An intracranial tumor growth model (BALB/c nude mice inoculate with H1975-luc cells)
  • Dosages: 10 and 25 mg/kg
  • Administration: --
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 4 mg/mL (7.21 mM)
Water Insoluble
Ethanol Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 554.64
Formula

C30H34N8O3

CAS No. 1903008-80-9
Storage powder
in solvent
Synonyms YH25448,GNS-1480
Smiles CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04410094 Not yet recruiting Drug: Lazertinib|Drug: Itraconazole|Drug: Rifampin Healthy Janssen Research & Development LLC August 14 2020 Phase 1
NCT04410081 Recruiting Drug: 14C-lazertinib Healthy Janssen Research & Development LLC July 14 2020 Phase 1
NCT04075396 Active not recruiting Drug: YH25448 Carcinoma Non-Small-Cell Lung Janssen Research & Development LLC|Yuhan Corporation October 16 2019 Phase 1|Phase 2
NCT04077463 Recruiting Drug: Lazertinib|Drug: JNJ-61186372 Carcinoma Non-Small-Cell Lung Janssen Pharmaceutical K.K. September 4 2019 Phase 1

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

EGFR Signaling Pathway Map

Related EGFR Products

Tags: buy Lazertinib|Lazertinib ic50|Lazertinib price|Lazertinib cost|Lazertinib solubility dmso|Lazertinib purchase|Lazertinib manufacturer|Lazertinib research buy|Lazertinib order|Lazertinib mouse|Lazertinib chemical structure|Lazertinib mw|Lazertinib molecular weight|Lazertinib datasheet|Lazertinib supplier|Lazertinib in vitro|Lazertinib cell line|Lazertinib concentration|Lazertinib nmr|Lazertinib in vivo|Lazertinib clinical trial|Lazertinib inhibitor|Lazertinib Protein Tyrosine Kinase inhibitor|Lazertinib smiles
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID